Background Recent studies indicate an increased frequency of mutations in the gene
encoding glucocerebrosidase (GBA), a deficiency of which causes Gaucher's disease, among …

… Ziv Gan-Or and Guy A. Rouleau received research grants from the Michael J. Fox … Ziv Gan-Or
is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (…

Background Genome-wide association studies (GWAS) in Parkinson's disease have increased
the scope of biological knowledge about the disease over the past decade. We aimed to …

Idiopathic REM sleep behaviour disorder (iRBD) is a powerful early sign of Parkinson’s
disease, dementia with Lewy bodies, and multiple system atrophy. This provides an …

Patients with isolated rapid-eye-movement sleep behaviour disorder (RBD) are commonly
regarded as being in the early stages of a progressive neurodegenerative disease involving α…

Objective: To better define the genotype-phenotype correlations between the type of GBA (glucosidase,
beta, acid) mutation, severe or mild, and the risk and age at onset (AAO), and …

The gold standard for a definitive diagnosis of Parkinson disease (PD) is the pathologic finding
of aggregated α-synuclein into Lewy bodies and for Alzheimer disease (AD) aggregated …

Background Restless legs syndrome is a prevalent chronic neurological disorder with
potentially severe mental and physical health consequences. Clearer understanding of the …

Rapid eye movement sleep behavior disorder and GBA mutations are both associated with
Parkinson's disease. The GBA gene was sequenced in idiopathic rapid eye movement sleep …

Glucocerebrosidase (GBA) mutations have been associated with Parkinson’s disease in
numerous studies. However, it is unknown whether the increased risk of Parkinson’s disease in …